Intra-Cellular Ther
(ITCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,152 | 144,008 | 77,477 | 150,365 | 137,108 |
| Marketable Securities | 393,619 | 370,596 | 462,981 | 443,290 | 493,383 |
| Receivables | 102,670 | 95,964 | 81,545 | 75,189 | 61,538 |
| Inventories | 42,986 | 41,895 | 28,341 | 23,920 | 23,597 |
| TOTAL | $702,425 | $698,073 | $706,094 | $737,957 | $759,756 |
| Non-Current Assets | |||||
| PPE Net | 1,789 | 1,656 | 1,779 | 1,913 | 2,084 |
| Other Non-Current Assets | 13,450 | 13,873 | 14,285 | 14,910 | 20,159 |
| TOTAL | $15,239 | $15,529 | $16,064 | $16,823 | $22,243 |
| Total Assets | $717,664 | $713,602 | $722,158 | $754,780 | $781,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,613 | 7,733 | 8,441 | 10,395 | 14,219 |
| Accrued Expenses | 53,277 | 49,079 | 37,723 | 42,653 | 36,000 |
| TOTAL | $103,092 | $92,080 | $79,587 | $83,236 | $77,410 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,891 | 14,432 | 14,961 | 15,474 | 19,167 |
| TOTAL | $13,891 | $14,432 | $14,961 | $15,474 | $19,167 |
| Total Liabilities | $116,983 | $106,512 | $94,548 | $98,710 | $96,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,238 | 96,092 | 95,926 | 95,280 | 94,705 |
| Common Shares | 10 | 10 | 10 | 9 | 9 |
| Retained earnings | -1,588,581 | -1,564,323 | -1,521,539 | -1,477,486 | -1,433,460 |
| Other shareholders' equity | -1,335 | -2,268 | -2,698 | -4,190 | -5,496 |
| TOTAL | $600,681 | $607,090 | $627,610 | $656,070 | $685,422 |
| Total Liabilities And Equity | $717,664 | $713,602 | $722,158 | $754,780 | $781,999 |